Corbevax COVID vaccine: Biological E vaccine gets DGCI approval to conduct phase 2/3 trials on children

Biological E’s anti-coronavirus shot Corbevax is an RBD protein sub-unit vaccine, which is currently undergoing phase 2/3 clinical trials on adults.



source https://www.jagranjosh.com/current-affairs/corbevax-covid-vaccine-biological-e-vaccine-gets-dgci-approval-to-conduct-phase-23-trials-on-children-1630575934-1

Comments

Check These Popular Posts